subject area of
- No acute antimigraine efficacy of CP-122,288, a highly potent inhibitor of neurogenic inflammation: Results of two randomized, double-blind, placebo-controlled clinical trials Journal Articles
- Sensory neuron and substance P involvement in symptoms of a zymosan-induced rat model of acute bowel inflammation Journal Articles
- USP15 regulates type I interferon response and is required for pathogenesis of neuroinflammation Journal Articles